4th Annual Oncology Summit Europe
24 - 25 Nov 2011
Hotel Concorde, Berlin, Germany
Meet the stakeholders at eyeforpharma’s 4th annual Oncology Europe Summit
Build a complimentary clinical and market access strategies by meeting the decision makers that shape the future of oncology. The agenda includes knowledge of NICE, NHS, IQWIG, AETS, AIFA, and other payors/regulators across Europe.
Speakers include
• Andrea Rappagliosi (VP, GSK)
• Bruno Osterwalder (SVP, Merck Serono)
• Omar Ali (Cost Modelling and Formulary Development Advisor, NICE/NHS)
• Charalabos-Markos Dintsios (Former Deputy Head, Departments of Health Economics, IQWIG, now VfA)
The topics they’ll cover include:
• German healthcare reform and new IQWIG oncology endpoint guidelines
• Cancer drugs fund, patient access schemes and value-based pricing in an oncology context
• Risk-sharing schemes and how they affect oncology access
• Building multiple stakeholder requirements into your evidence generation strategy
To download the full brochure click here – www.eyeforpharma.com/oncology
No items were found.